Asian Pacific Journal of Cancer Prevention

  • 제14권11호
  • /
  • Pages.6979-6983
  • /
  • 2013
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Suitability/Unsuitability of Cell Proliferation as an Indicator of Malignant Potential in Oral Lichen Planus: an Immunohistochemical Study

  • Zargaran, Massoumeh (Dental Research Center, Department of Oral and Maxillofacial Pathology, Dental School, Hamadan University of Medical Sciences) ;
  • Jamshidi, Shokoofeh (Dental Research Center, Department of Oral and Maxillofacial Pathology, Dental School, Hamadan University of Medical Sciences) ;
  • Eshghyar, Nosratollah (Department of Oral and Maxillofacial Pathology, Dental School, Tehran University of Medical Sciences) ;
  • Moghimbeigi, Abbas (Department of Biostatistics and Epidemiology, School of Public Helth, Hamadan University of Medical Sciences)
  • 발행 : 2013.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Oral lichen planus (OLP) is categorized as premalignant lesion although its malignant potential is a matter of controversy. The objective of this study was to investigate Ki67 expression in OLP, oral epithelial dysplasia and oral squamous cell carcinoma (OSCC). Materials and Methods: Expression of Ki67 was evaluated through immunohistochemistry (IHC) in groups of A (17 cases of epithelial hyperplasia), B (16 cases of OLP), C1 (10 cases of mild epithelial dysplasia), C2 (10 cases of severe epithelial dysplasia), D1 (10 cases of well-differentiated OSCC), and D2 (10 cases of poorly-differentiated OSCC). Results: There was a significant difference in Ki67 expression based on quantitative analysis among the six studied groups as well as group B compared bilaterally with groups C2, D1 and D2 (p< 0.0001). However, there was no significant difference between groups B and C1 or between groups D1 and D2 (p> 0.05). Conclusions: Based on the results of the present study it may not be possible to definitely consider malignant transformation potential for OLP. However, expression of Ki67 was significantly higher in OLP than that of epithelial hyperplasia with no significant difference from that of mild epithelial dysplasia. This should be considered by clinicians to carefully and regularly follow up OLP lesions to detect potential subtle changes at an early stage.

키워드

참고문헌

  1. Bascones-Ilundain C, Gonzalez-Moles MA, Campo-Trapero J, et al (2008). No differences in caspase-3 and Bax expression in atrophic-erosive vs. reticular oral lichen planus. J Eur Acad Dermatol Venereol, 22, 204-12.
  2. Bloor BK, Malik FK, Odell EW, Morgen PR (1999). Quantitative assessment of apoptosis in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 88, 187-95. https://doi.org/10.1016/S1079-2104(99)70116-2
  3. Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N, Mori-Estevez AD, Sanchez-Acuna G (2013). Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors. Med Oral Patol Oral Cir Bucal, 18, 174-9.
  4. Brzak BL, Mravak-Stipeti. M, Canjuga I, et al (2012). The frequency and malignant transformation rate of oral lichen planus and leukoplakia--a retrospective study. Coll Antropol, 36, 773-7.
  5. da Silva Fonseca LM, do Carmo MA (2001). Identification of the Ag-NORs, PCNA and ck16 proteins in oral lichen planus lesions. Oral Dis, 7, 344-8. https://doi.org/10.1034/j.1601-0825.2001.00747.x
  6. de Sousa FA, Paradella TC, Carvalho YR, Rosa LE (2009a).Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma. Ann Diagn Pathol, 13, 308-12. https://doi.org/10.1016/j.anndiagpath.2009.06.001
  7. de Sousa FA, Paradella TC, Carvalho YR, Rosa LE B (2009b).Comparative analysis of cell proliferation ratio in oral lichen planus, epithelial dysplasia and oral squamous cell carcinoma. Med Oral Patol Oral Cir Buca, 14, 563-7.
  8. Dragomir LP, Simionescu C, M.rg.ritescu C, et al (2012). P53, p16 and Ki67 immunoexpression in oral squamous carcinomas. Rom J Morphol Embryol, 53, 89-93.
  9. Eisenberg E (2000). Oral lichen planus: a benign lesion. J Oral Maxillofac Surg, 58, 1278-85. https://doi.org/10.1053/joms.2000.16629
  10. Garcia-Garcia V, Bascones Martinez A, Martinelli-Klay CP, et al (2012). New perspectives on the dynamic behaviour of oral lichen planus. Eur J Dermatol, 22, 172-7.
  11. Georgakopoulou EA, Achtari MD, Achtaris M, Foukas PG, Kotsinas A (2012). Oral lichen planus as a preneoplastic inflammatory model. J Biomed Biotechnol, 2012, 759626.
  12. Gonzalez Moles MA, Esteban F, Ruiz-Avila I, et al (2009). A role for the substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus. Oral Dis, 15, 162-9. https://doi.org/10.1111/j.1601-0825.2008.01504.x
  13. Gorugantula LM, Rees T, Plemons J, Chen HS, Cheng YS (2012). Salivary basic fibroblast growth factor in patients with oral squamous cell carcinoma or oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol, 114, 215-22. https://doi.org/10.1016/j.oooo.2012.03.013
  14. Hadzi-Mihailovic M, Cakic S, Jankovic S, et al (2012). Ki-67 expression in oral lichen planus. J BUON, 17, 132-7.
  15. Hirota M, Ito T, Okudela K, et al (2002). Cell proliferation activity and the expression of cell cycle regulatory proteins in oral lichen planus. J Oral Pathol Med, 31, 204-12. https://doi.org/10.1034/j.1600-0714.2002.310403.x
  16. Jaafari-Ashkavandi Z, Mardani M, Pardis S, Amanpour S (2011).Oral mucocutaneous diseases: clinicopathologic analysis and malignant transformation. J Craniofac Surg, 22, 949-51. https://doi.org/10.1097/SCS.0b013e31820fe1f0
  17. Lee JJ, Kuo MY, Cheng SJ, et al (2005). Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Oral Surg Oral MedOral Pathol Oral Radiol Endod, 99, 471-8. https://doi.org/10.1016/j.tripleo.2004.10.018
  18. Lin HP, Wang YP, Chia JS, Sun A (2011). Modulation of serum antinuclear antibody levels by levamisole treatment in patients with oral lichen planus. J Formos Med Assoc, 110, 316-21. https://doi.org/10.1016/S0929-6646(11)60047-8
  19. Liu Y, Messadi DV, Wu H, Hu S (2010). Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer. Med Hypotheses, 75, 492-4. https://doi.org/10.1016/j.mehy.2010.07.002
  20. Mattila R, Ahlfors E, Syrjanen S (2011). CD27 and CD38 lymphocytes are detected in oral lichen planus lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 111, 211-7. https://doi.org/10.1016/j.tripleo.2010.09.075
  21. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Bucci E (2004). Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol, 40, 120-30. https://doi.org/10.1016/j.oraloncology.2003.08.001
  22. Montebugnoli L, Badiali G, Marchetti C, et al (2009).Prognostic value of Ki67 from clinically and histologically 'normal' distant mucosa in patients surgically treated for oral squamous cell carcinoma: a prospective study. Int J Oral Maxillofac Surg, 38, 1165-72. https://doi.org/10.1016/j.ijom.2009.06.011
  23. Montebugnoli L, Venturi M, Gissi DB, et al (2011).Immunohistochemical expression of p16 (INK4A) protein in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 112, 222-7. https://doi.org/10.1016/j.tripleo.2011.02.029
  24. Ranganathan K, Kavitha R (2011). Proliferation and apoptosis markers in oral submucous fibrosis. J Oral Maxillofac Pathol, 15, 148-53. https://doi.org/10.4103/0973-029X.84478
  25. Rodstrom PO, Jontell M, Mattsson U, Holmberg E (2004). Cancer and oral lichen planus in a Swedish population. Oral Oncol, 40, 131-8. https://doi.org/10.1016/S1368-8375(03)00134-9
  26. Roopashree MR, Gondhalekar RV, Shashikanth MC, et al (2010) . Pathogenesis of oral lichen planus--a review. J Oral Pathol Med, 39, 729-34. https://doi.org/10.1111/j.1600-0714.2010.00946.x
  27. Safadi RA, Al Jaber SZ, Hammad HM, Hamasha AA (2010).Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study. Arch Oral Biol, 55, 454-61. https://doi.org/10.1016/j.archoralbio.2010.03.019
  28. Shen ZY, Liu W, Feng JQ, Zhou HW, Zhou ZT (2011). Squamous cell carcinoma development in previously diagnosed oral lichen planus: de novo or transformation? Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 112, 592-6. https://doi.org/10.1016/j.tripleo.2011.05.029
  29. Siar CH, Mah MC, Gill PP (2011). Risk of the contralateral mucosa in patients with oral potentially malignant disorders. Asian Pac J Cancer Prev, 12, 631-5.
  30. Sousa FA, Paradella TC, Carvalho YR, Rosa LE (2009a). Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia. J Oral Sci, 51, 117-21. https://doi.org/10.2334/josnusd.51.117
  31. Sousa FA, Paradella TC, Brandao AA, Rosa LE (2009b).Comparative study of cell alterations in oral lichen planus and epidermoid carcinoma of the mouth mucosa. Braz J Otorhinolaryngol, 75, 245-8. https://doi.org/10.1016/S1808-8694(15)30785-0
  32. Sousa FA, Paradella TC, Brandao AA, Rosa LE (2009c). Oral lichen planus versus epithelial dysplasia: difficulties in diagnosis. Braz J Otorhinolaryngol, 75, 716-20. https://doi.org/10.1590/S1808-86942009000500017
  33. Taniguchi Y, Nagao T, Maeda H, Kameyama Y, Warnakulasuriya KA (2002). Epithelial cell proliferation in oral lichen planus. Cell Prolif, 35 ,103-9. https://doi.org/10.1046/j.1365-2184.35.s1.11.x
  34. Tipoe GL, Jin Y, White FH (1996). The relationship between vascularity and cell proliferation in human normal and pathological lesions of the oral cheek epithelium. Eur J Cancer B Oral Oncol, 32, 24-31. https://doi.org/10.1016/0964-1955(95)00049-6
  35. Watanabe S, Watanabe R, Oton-Leite AF, et al (2010). Analysis of cell proliferation and pattern of invasion in oral squamous cell carcinoma. J Oral Sci, 52, 417-24. https://doi.org/10.2334/josnusd.52.417

피인용 문헌

  1. In situ carcinoma developed over oral lichen planus: a case report with analysis of BUB3, p16, p53, Ki67 and SOX4 expression vol.23, pp.4, 2015, https://doi.org/10.1590/1678-775720150058
  2. Oral lichenoid lesions: distinguishing the benign from the deadly vol.30, pp.1530-0285, 2017, https://doi.org/10.1038/modpathol.2016.121
  3. Comparative study of β-catenin and CD44 immunoexpression in oral lichen planus and squamous cell carcinoma vol.57, pp.7, 2018, https://doi.org/10.1111/ijd.14007
  4. Cellular cannibalism and lichen planus malignancy: A suggestive hypothesis vol.9, pp.2, 2018, https://doi.org/10.1111/jicd.12321
  5. Markers of Oral Lichen Planus Malignant Transformation vol.2018, pp.1875-8630, 2018, https://doi.org/10.1155/2018/1959506